BioCentury
ARTICLE | Company News

TeOra Health, Aequus Pharmaceuticals deal

August 24, 2015 7:00 AM UTC

Aequus acquired specialty pharmaceutical company TeOra for 420,000 shares of Aequus, valued at C$243,600 ($191,616) based on Aequus’ close of C$0.58 on July 27, the day before the deal closed. TeOra i...